dc.contributor.author | Tavil, Betül | |
dc.contributor.author | Aytac, Selin | |
dc.contributor.author | Balcı Isık, Yasemin | |
dc.contributor.author | Unal, Sule | |
dc.contributor.author | Kuskonmaz, Baris | |
dc.contributor.author | Yetgin, Sevgi | |
dc.contributor.author | Gurgey, Aytemiz | |
dc.contributor.author | Tuncer, Murat | |
dc.contributor.author | Gumruk, Fatma | |
dc.contributor.author | Uckan, Duygu | |
dc.contributor.author | Cetin, Mualla | |
dc.date.accessioned | 2020-10-21T12:40:00Z | |
dc.date.available | 2020-10-21T12:40:00Z | |
dc.date.issued | 2010 | |
dc.identifier.uri | http://hdl.handle.net/11655/23010 | |
dc.language.iso | en | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | tr_TR |
dc.subject | FLAG-IDA, leukemia | tr_TR |
dc.title | Fludarabine, cytarabine, granulocyte colony-stimulating factor, and idarubicin (FLAG-IDA) for the treatment of children with poor-prognosis acute leukemia: the Hacettepe experience. | tr_TR |
dc.type | info:eu-repo/semantics/article | tr_TR |
dc.contributor.department | Çocuk Sağlığı ve Hastalıkları | tr_TR |
dc.description.index | WoS | tr_TR |
dc.funding | Yok | tr_TR |